NewsLast post failed miserably!
BROADWAY GOLD MINING LTD. ANNOUNCES PROPOSED ACQUISITION OF MIND MEDICINE, INC. AND RELATED FINANCING TRANSACTIONS
Broadway Gold Mining Ltd. has entered into a binding letter of intent with Mind Medicine Inc., a privately held issuer incorporated under the laws of Delaware (MMED), which outlines the general terms and conditions pursuant to which Broadway and MMED have agreed to complete a transaction that will result in a reverse takeover of Broadway by the current shareholders of MMED. The LOI was negotiated at arm's length and is effective as of July 26, 2019.
MMED is assembling a compelling drug development pipeline of psychedelic inspired medicines planning or undertaking FDA trials. The company plans to grow its pipeline of psychedelic inspired medicines through acquisitions, joint ventures and collaborative development agreements.
MMED is developing a transformational treatment for opioid addiction to address the growing U.S. opioid crisis. MMED holds 100% of right, title and assets connected with the drug development project for 18-methoxycoronaridine or 18-MC (the "18-MC Program"), a synthetic congener of the naturally-occurring psychedelic compound ibogaine.